ClinicalTrials.Veeva

Menu

A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population

P

Peking University

Status

Unknown

Conditions

Familial Hypercholesterolemia

Treatments

Other: familial hypercholesterolemia

Study type

Observational

Funder types

Other

Identifiers

NCT04958629
M2021098

Details and patient eligibility

About

To determine the prevalence and the prognosis in a corhort of patients with familial hypercholesterolemia (FH).

Full description

This study aims to achieve the following goals through prospective cohort study and statistical analysis: (1) to determine the prevalence of familial hypercholesterolemia (FH) in healthy people with hypercholesterolemia.(2) Compared with non FH population, the relative risk of atherosclerotic cardiovascular disease (ASCVD) in FH patients in China was calculated, and the risk prediction model of ASCVD in FH patients was constructed by using biochemical results, imaging data, biomarkers and other indicators.(3) To evaluate the benefits of different lipid-lowering strategies for FH patients in China.(4) To analyze the gene carriers of FH patients in China.

Enrollment

318 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with definite diagnosis of hyperlipidemia.

Exclusion criteria

  1. Age < 18.
  2. Do not agree to participate in this study.
  3. secondary hypercholesterolemia.
  4. Phytosteronemia.

Trial design

318 participants in 2 patient groups

non-FH Group
FH Group
Treatment:
Other: familial hypercholesterolemia

Trial contacts and locations

0

Loading...

Central trial contact

Wei Gao, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems